Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 3
2006 6
2007 5
2008 8
2009 5
2010 4
2011 2
2012 6
2013 6
2014 5
2015 11
2016 5
2017 4
2018 4
2019 11
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior.
Moschetti G, Amodeo G, Paladini MS, Molteni R, Balboni G, Panerai A, Sacerdote P, Franchi S. Moschetti G, et al. Among authors: balboni g. Brain Behav Immun. 2019 Nov;82:422-431. doi: 10.1016/j.bbi.2019.09.012. Epub 2019 Sep 13. Brain Behav Immun. 2019. PMID: 31525509 Free article.
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system.
Maftei D, Ratano P, Fusco I, Marconi V, Squillace S, Negri L, Severini C, Balboni G, Steardo L, Bronzuoli MR, Scuderi C, Campolongo P, Lattanzi R. Maftei D, et al. Among authors: balboni g. Neuropharmacology. 2019 Nov 1;158:107739. doi: 10.1016/j.neuropharm.2019.107739. Epub 2019 Aug 10. Neuropharmacology. 2019. PMID: 31408628
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
Paul A, Viswanathan GK, Mahapatra S, Balboni G, Pacifico S, Gazit E, Segal D. Paul A, et al. Among authors: balboni g. ACS Chem Neurosci. 2019 Aug 21;10(8):3510-3520. doi: 10.1021/acschemneuro.9b00123. Epub 2019 Jul 8. ACS Chem Neurosci. 2019. PMID: 31282646
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated.
Polo S, Díaz AF, Gallardo N, Leánez S, Balboni G, Pol O. Polo S, et al. Among authors: balboni g. Front Pharmacol. 2019 Mar 26;10:283. doi: 10.3389/fphar.2019.00283. eCollection 2019. Front Pharmacol. 2019. PMID: 30971925 Free PMC article.
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy.
Moschetti G, Amodeo G, Maftei D, Lattanzi R, Procacci P, Sartori P, Balboni G, Onnis V, Conte V, Panerai A, Sacerdote P, Franchi S. Moschetti G, et al. Among authors: balboni g. J Neuroinflammation. 2019 Apr 17;16(1):89. doi: 10.1186/s12974-019-1461-0. J Neuroinflammation. 2019. PMID: 30995914 Free PMC article.
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors.
Nocentini A, Moi D, Balboni G, Onnis V, Supuran CT. Nocentini A, et al. Among authors: balboni g. Bioorg Chem. 2018 Apr;77:293-299. doi: 10.1016/j.bioorg.2018.01.023. Epub 2018 Jan 31. Bioorg Chem. 2018. PMID: 29421705
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
Nocentini A, Moi D, Balboni G, Salvadori S, Onnis V, Supuran CT. Nocentini A, et al. Among authors: balboni g. Bioorg Chem. 2018 Apr;77:633-639. doi: 10.1016/j.bioorg.2018.02.021. Epub 2018 Feb 23. Bioorg Chem. 2018. PMID: 29502024
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity.
Baldisserotto A, Demurtas M, Lampronti I, Moi D, Balboni G, Vertuani S, Manfredini S, Onnis V. Baldisserotto A, et al. Among authors: balboni g. Eur J Med Chem. 2018 Aug 5;156:118-125. doi: 10.1016/j.ejmech.2018.07.001. Epub 2018 Jul 2. Eur J Med Chem. 2018. PMID: 30006157
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.
Moi D, Foster PA, Rimmer LG, Jaffri A, Deplano A, Balboni G, Onnis V, Potter BVL. Moi D, et al. Among authors: balboni g. Eur J Med Chem. 2019 Nov 15;182:111614. doi: 10.1016/j.ejmech.2019.111614. Epub 2019 Aug 12. Eur J Med Chem. 2019. PMID: 31422224
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes.
Park B, Nam JH, Kim JH, Kim HJ, Onnis V, Balboni G, Lee KT, Park JH, Catto M, Carotti A, Lee JY. Park B, et al. Among authors: balboni g. Bioorg Med Chem Lett. 2017 Mar 1;27(5):1179-1185. doi: 10.1016/j.bmcl.2017.01.068. Epub 2017 Jan 26. Bioorg Med Chem Lett. 2017. PMID: 28189420
84 results
Jump to page
Feedback